One-time charges on two projects will lead to a 2009 loss for radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium.
IBA announced that it as has "considerably increased" its research and development investment in recent years and found that it "probably cannot avoid significant cost overruns on completion of two of these projects."
The net result could be charges totaling 10 million to 15 million euros ($15 million to $22.5 million U.S.), negatively affecting the company's final numbers for operating profit and resulting in a net loss for 2009, IBA said.
Related Reading
IBA scores financing, December 18, 2009
IBA wins court order to reapply for contract, December 4, 2009
IBA lands Italian install, December 3, 2009
IBA launches Proteus Nano, November 3, 2009
IBA launches proton rental program, October 30, 2009
Copyright © 2010 AuntMinnie.com
